Asthma in childhood

Fernando Maria de Benedictis1, Marina Attanasi2

  • 1Dept of Pediatrics, Salesi Children's Hospital, Ancona, Italy pediatria@fmdebenedictis.it.

Insights

The number of early-life respiratory infections, not the specific virus, predicts childhood asthma. Biomarkers like exhaled compounds aid early asthma detection and prediction in wheezy children.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Allergy & Immunology

Background:

  • Childhood asthma remains a significant health concern with complex etiological factors.
  • Identifying predictors for asthma development and exacerbation is crucial for effective prevention strategies.
  • Current diagnostic and monitoring tools for pediatric asthma require refinement.

Purpose of the Study:

  • To review recent advancements in understanding childhood asthma presented at the 2015 European Respiratory Society International Congress.
  • To explore novel biomarkers and risk factors associated with asthma development, exacerbation, and treatment response in children.
  • To highlight the importance of personalized monitoring and cautious use of interventions in pediatric asthma management.

Main Methods:

  • Review of presentations from the Paediatric Clinical Year in Review session at the 2015 European Respiratory Society International Congress.
  • Analysis of data linking early-life respiratory infections to later asthma development.
  • Evaluation of exhaled volatile organic compounds and gene expression as potential asthma biomarkers.
  • Discussion of factors influencing asthma exacerbations and bronchodilator response in children.

Main Results:

  • The frequency of respiratory episodes in early life, rather than the specific viral trigger, is associated with subsequent asthma development.
  • Exhaled volatile organic compounds, combined with inflammation gene expression, significantly improve asthma prediction in preschool children.
  • Personal communication is emphasized as more critical than monitoring tools for children and adolescents with asthma.
  • Systemic corticosteroids do not alter the long-term prognosis of a first viral-induced wheezing episode and require cautious use.
  • Stress and specific gene polymorphisms are linked to diminished bronchodilator response in pediatric asthma patients.

Conclusions:

  • Asthma development is influenced by the burden of early respiratory infections.
  • Novel biomarkers like exhaled volatile organic compounds show promise for early asthma detection and prediction.
  • Personalized monitoring and careful consideration of exacerbating factors, including stress and genetics, are essential for managing childhood asthma effectively.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
4.0K